Ocera Therapeutics fka OCRX

[ghmm]

I looked over the report and while its long it repeats a lot! Seems to be a lot of the company line/presentation. Only thing I caught of interest which perhaps I missed OCRX disclosing at some point is this about the NIH study

Recently, an additional cohort of 12 patients was added to receive doses of 20 g/24hr, which the Company believes is the appropriate dose in this population.

The other thing in their modeling they use a $6,500 price for 5 day treatment. For the oral they model $1600/mo and say that is comparable to Xifaxan. There is also a nice table of IP (page 23).